The addition of two new AI-enabled models for the latest version of the NeuroQuant Brain Tumor software facilitates automated tracking of the progression of brain tumors and meningiomas.
Cortechs.ai has launched an updated version of the NeuroQuant Brain Tumor software, which reportedly provides full artificial intelligence (AI)-powered automation for segmentation and volumetric assessment of brain metastases and meningiomas.
The company noted that the NeuroQuant Brain Tumor software has been updated with two new AI-enabled models that facilitate improved neuroradiology workflows and enhanced tracking of the progression of brain metastases and meningiomas.
The updated NeuroQuant Brain Tumor software offers "critical insights into changes in tumor volume over time" for brain metastases and meningiomas, according to Nikdokht Farid, M.D., a professor of neuroradiology at the University of California, San Diego (UCSD). (Image courtesy of Cortechs.ai .)
Nikdokht Farid, M.D., a professor of neuroradiology at the University of California, San Diego (UCSD), said the automated capabilities of the NeuroQuant Brain Tumor software offer significant benefit to neuroradiologists.
"NeuroQuant® Brain Tumor's longitudinal tracking capabilities offer critical insights into changes in tumor volume over time, facilitating more accurate monitoring of treatment response and more informed clinical decision-making. With the latest software release, which offers automated segmentation and tracking of brain metastases and meningiomas, this tool has tremendous potential to improve workflow efficiency and clinical confidence in detecting, measuring, and following brain metastases and meningiomas," said Dr. Farid, the vice president of the American Association for Women in Radiology (AAWR).
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.